Skip to main content

Advertisement

Table 1 HCV JFH-1 neutralization assay

From: A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

Genotype Nba M/Fb ratio Age (yr) HCV RNAc (log IU/mL) Mean ± SDd Rangee
1a 11 7/4 43 ± 6 5.90 ± 0.6 2.046 ± 0.671 0.926 – 3.121
1b 11 5/6 48 ± 16 6.16 ± 0.5 1.747 ± 0.462 0.934 – 2.356
2 11 9/2 63 ± 12 5.50 ± 0.9 2.128 ± 0.365 1.486 – 2.742
3 12 8/4 40 ± 11 5.66 ± 0.6 2.148 ± 0.478 1.326 – 2.977
4 10 4/6 45 ± 11 6.07 ± 0.7 1.786 ± 0.236 1.453 – 2.152
5 2 1/1 66 ± 14 6.06 ± 0.6 1.755 ± 0.005 nd
all 57 34/23 48 ± 15 5.83 ± 0.7 1.970 ± 0.491 0.934 – 3.121
  1. aNumber of samples tested.
  2. bF, female; M, male.
  3. cHCV RNA measured using the Amplicor HCV Monitor assay, version 2.0 (Roche Diagnostics, Meylan, France) and expressed in log equivalents of IU/mL.
  4. dNeutralizing anti-HCV antibodies titers expressed in log units; mean ± SD
  5. eRange of neutralizing anti-HCV antibodies titers, expressed in log units